Cigna Pharmacy and other service costs payable decreased by 14841.9% to -$4.57B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3485.2%, from $135.00M to -$4.57B. Over 3 years (FY 2021 to FY 2025), Pharmacy and other service costs payable shows relatively stable performance with a -1.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase in payables provides a cash flow benefit by delaying cash outflows, while a decrease indicates faster settlement of obligations.
This measures the change in payables related to pharmacy benefit management and other service-related costs. It reflects...
Specific to PBMs and healthcare services; peers manage this to optimize cash conversion cycles.
operating_increase_decrease_in_pharmacy_and_service_cost_931877| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $708.00M | $234.00M | $604.00M | -$74.00M | $1.20B | $244.00M | $392.00M | $539.00M | $1.01B | $703.00M | $4.64B | $3.18B | $1.16B | $0.00 | $135.00M | $860.00M | $842.00M | $31.00M | -$4.57B |
| QoQ Change | — | -66.9% | +158.1% | -112.3% | >999% | -79.6% | +60.7% | +37.5% | +87.0% | -30.3% | +559.6% | -31.4% | -63.6% | -100.0% | — | +537.0% | -2.1% | -96.3% | <-999% |
| YoY Change | — | — | — | — | +69.2% | +4.3% | -35.1% | +828.4% | -15.9% | +188.1% | +760.3% | +215.8% | +64.9% | — | -97.1% | -73.0% | -27.4% | — | <-999% |